Abstract
Head and neck squamous cell carcinoma (HNSCC), including carcinomas of the oral cavity (OSCC), remains a challenging cancer to treat with no improvement in survival rates over the past 50 years. Thus, there is an urgent need to discover more reliable therapeutic targets and biomarkers for this disease. Kallikrein 5 (KLK5) is a member of the tissue kallikrein family implicated in OSCC deve…